Visual Outcomes Of 129 Patients With Bilateral Panoptix Implantation: A Prospective, Multicenter, Real-World Observational Study
Published 2024 - 42nd Congress of the ESCRS
Reference: FP09.12 | Type: Free paper | DOI: 10.82333/mvyp-ng89
Authors: Yan Wen* 1 , Maosheng Chen 1 , Qiong Liao 2 , Jilin Tan 1 , Zhiqing He 3 , Lei Wu 4 , Xiaocheng Zhang 5 , Zhengdong Xu 6
1Chongqing Aier Eye Hospital,Chongqing,China, 2Chongqing Eye and Vision Care Hospital,Chongqing,China, 3Kunming IWE eye hospital,Chongqing,China, 4Chengdu Aier Eye Hospital,Chengdu,China, 5Chongqing Aier Mega Eye Hospital,Chongqing,China, 6Chengdu East Aier Eye Hospital,Chengdu,China
Purpose
To investigate the visual performance of PanOptix in multicenter real-world observational study and broader variety of patients through routine clinical practice.
Setting
A prospective, multicenter, real-world observational study.
Methods
129 cataract patients (258eyes) undergoing cataract surgery with bilateral implantation of PanOptix at 6 ophthalmic centers from October 1, 2021 to Sep 20, 2023 were included. The primary endpoint was the proportion of subjects achieving 0.20 logMAR or better for binocular uncorrected visual acuity at all distances at 3 months postoperatively. Visual acuity, defocus curve (+2 D to -4 D), manifest refraction, Catquest-9SF and IOLSAT questionnaire were also evaluated.
Results
94% of patients with eyes achieved 0.20 logMAR or better of the composite binocular uncorrected visual acuity at distance (5 m), intermediate (60 cm) and near (40 cm) at 3-month follow-up . The binocular UCDVA and BCDVA, UCIVA and DCIVA, UCNVA and DCNVA at 1 week, 1 month and 3 months postoperatively were significantly improved compared to preoperative values (p<0.05). The spherical equivalent refractions were within ± 0.5 D of the target refraction. The binocular defocus curve showed that the visual acuity was better than 0.2 logMAR within the range of +1 D to -2.5 D, indicating excellent visual acuity at distance, intermediate and near. The spectacle dependence rate and satisfaction of patients were higher than 90%.
Conclusions
Bilateral implantation of PanOptix provided good full range of vision for cataract patients in a real-world setting, with a desired spectacle independence rate and patient satisfaction.